Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Calendar &
upcoming reports

30 August 2023

Interim report Q2, 2023

14 September 2023

Pareto Securities

29 November 2023

Interim report Q3, 2023

28 February 2024

Year end report 2023

Show all posts